This week Appistry, big data analytics company operating out of St. Louis, announced that it has secured a new partnership with the Agency for Science, Technology, and Research’s Genome Institute of Singapore (GIS). Going forward, Appistry will support the GIS’ efforts to become a major genomics research hub in Asia.
Similarly to the Broad Institute, GIS will utilize Appistry’s robust analytics tools to aid its ongoing studies of the human genome. GIS gathers and analyzes genomic data in order to gain insight into the development of medical complications and uncover advanced methods of researching the human genome. The organization focus of research includes stem cell, developmental biology, cancer therapeutics, infectious disease, and genomic technologies research, among others.
The bioinformatics market is expected to generate $2.3 billion this year alone. According to a report published by Transparency Market Research, the industry is projected to grow more than three times that by 2018.
Sultan Meghji, Appistry vice president of product strategy, said the partnership will greatly accelerate and improve the efficiency of GIS’ genome research going forward.
“The push toward translational and personalized medicine requires organizations to wrap their science within systems and applications that can provide actionable results from big data,” said Meghji. “Our global partnership with Broad and our regional partnership with GIS better enable our customers to capture the scientific best practices and capabilities they need in an environment that scales to modern throughput demands.”
The new partnership was announced at this week’s World Genome Data Analysis Summit in San Francisco, where Meghji gave talk on managing big data challenges in the lab. You can watch the talk here, or visit Appistry.com to find out more about the St. Louis big data company.